SCHEMBL2485246

SCHEMBL2485246

O=C1COC(C(Br)(Br)Br)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17211649 0.76 SMN1; SMN2 (0.33)
SCHEMBL10623492 0.62
SCHEMBL3557928 0.62
SCHEMBL6310764 0.62
SCHEMBL2559278 0.60
SCHEMBL7679324 0.60
SCHEMBL23389134 0.58
SCHEMBL5406897 0.58 CYP2C19 (0.46)
SCHEMBL8079036 0.58 MEN1 (0.45)
SCHEMBL14578019 0.58 CYP2C19 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3147278-B1 COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS UNIV TENNESSEE RES FOUND (US) 2020-02-12 EP disclosed
US-10300037-B2 SARMs and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2019-05-28 US disclosed
US-20190055192-A1 SELECTIVE ANDROGEN RECEPTOR MODULATOR AND METHODS OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2019-02-21 US disclosed
US-10010521-B2 SARMs and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2018-07-03 US disclosed
US-20180116994-A1 SARMS AND METHOD OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2018-05-03 US disclosed
US-20180071242-A1 SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2018-03-15 US disclosed
US-9844528-B2 SARMs and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2017-12-19 US disclosed
US-9730908-B2 SARMs and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2017-08-15 US disclosed
EP-3147278-A1 COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS University of Tennessee Research Foundation (US) 2017-03-29 EP disclosed
US-20170014371-A1 SARMS AND METHOD OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2017-01-19 US disclosed
EP-2054049-A2 SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF University of Tennessee Research Foundation (US) 2009-05-06 EP disclosed
EP-2038252-A2 SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF University of Tennessee Research Foundation (US) 2009-03-25 EP disclosed
US-20080076828-A1 Substituted acylanilides and methods of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2008-03-27 US disclosed
US-20080076829-A1 Substituted acylanilides and methods of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2008-03-27 US disclosed
US-20080057068-A1 SARMS and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2008-03-06 US disclosed
WO-2008024456-A2 SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2008-02-28 WO disclosed
WO-2008008433-A2 SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2008-01-17 WO disclosed
US-20070173546-A1 Selective androgen receptor modulators and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2007-07-26 US disclosed
US-20070161608-A1 Selective androgen receptor modulators for treating muscle wasting UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2007-07-12 US disclosed
US-20070123563-A1 Selective androgen receptor modulators and method of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2007-05-31 US disclosed